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We thank Drs. Sasieta and Escalante for their interest in our article (1). We certainly agree 
with their conclusion that we might have misclassified the apparent etiology of some of the 
tuberculosis (TB) recurrences in our cohort. In addition to other listed limitations that might 
have led to misclassification, a possibility that they correctly raise is that some of the 15% 
whom we classified as having novel reinfection might, in fact, have had undetected mixed 
infections (i.e., coinfection) during the initial TB episode.
The frequency of mixed TB infections in the United States is difficult to ascertain given that 
the National Tuberculosis Genotyping Service typically offers genotyping for only one 
isolate from every culture-positive TB case (2, 3). However, just as state public health 
laboratories have the option to submit multiple isolates to help investigate a possible false-
positive Mycobacterium tuberculosis culture, they also have the option to submit multiple 
isolates if they suspect mixed infections (4). None of the initial or subsequent isolates in this 
analysis were flagged as either suspected false positives or mixed infections. The isolates 
from the 20 pairs of TB episodes that we classified as reinfections had substantially different 
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M. tuberculosis genotype patterns (further details in Table 2 [1]), well beyond the single 
mycobacterial interspersed repeat units–variable number tandem repeat [MIRU–VNTR] 
locus or RFLP band difference occasionally seen with in situ clonal evolution.
Because our TB investigation experience (5) has taught us that cases along the same chain of 
transmission typically match by current genotyping methods (i.e., spoligotyping and 24-
locus MIRU–VNTR [2,3]), we were not surprised that 85% of the recurrences that we 
examined had a genotype that matched that of the earlier TB episode (1), suggesting that 




N.R.G. is supported by a Mid-Career Development Award from the National Institutes of Health (K24AI114444) 
and Emory Centers for AIDS Research (P30 AI050409).
References
1. Interrante JD, Haddad MB, Kim L, Gandhi NR. Exogenous reinfection as an etiology of late 
recurrent tuberculosis in the United States. Ann Am Thorac Soc. 2015 in press. 
2. Centers for Disease Control and Prevention. New CDC program for rapid genotyping of 
Mycobacterium tuberculosis isolates. MMWR Morb Mortal Wkly Rep. 2005; 54:47.
3. Centers for Disease Control and Prevention. Tuberculosis genotyping—United States, 2004–2010. 
MMWR Morb Mortal Wkly Rep. 2012; 61:723–725. [PubMed: 22971745] 
4. Buff AM, Sosa LE, Hoopes AJ, Buxton-Morris D, Condren TB, Hadler JL, Haddad MB, Moonan 
PK, Lobato MN. Two tuberculosis genotyping clusters, one preventable outbreak. Public Health 
Rep. 2009; 124:490–494. [PubMed: 19618785] 
5. Mitruka K, Oeltmann JE, Ijaz K, Haddad MB. Tuberculosis outbreak investigations in the United 
States 2002-2008. Emerg Infect Dis. 2011; 17:425–431. [PubMed: 21392433] 
Interrante et al. Page 2
Ann Am Thorac Soc. Author manuscript; available in PMC 2016 December 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
